We’ve been following Dex-Net’s progress towards universal grasping for several years now, and today in a paper in Science Robotics, UC Berkeley is presenting Dex-Net 4.0. The new and exciting bit about this latest version of Dex-Net is that it’s able to successfully grasp 95 percent of unseen objects at a rate of 300 per hour, thanks to some added ambidexterity that lets the robot dynamically choose between two different kinds of grippers.
SQZ Biotech is on a roll. Months after securing $72 million in a Series C financing round and expanding a developmental agreement with pharma giant Roche worth up to $1 billion, the company is now expanding its footprint in Watertown, Mass.
Although that is good news, cancer is the second-most common cause of death in the U.S., with more than 1.7 million new cancer cases each year and more than 600,000 cancer deaths. The report notes that one of the biggest factors in decreased cancer rates are lower tobacco smoking rates.
In its last days, the Cassini spacecraft looped between Saturn and its rings so that Earth-based radio telescopes could track the gravitational tug of each. Scientists have now used these measurements to determine the mass of the rings and estimate its age, which is young: 10-100 million years. This supports the hypothesis that the rings are rubble from a comet or Kuiper Belt object captured late in Saturn’s history.
A powerful new technique combines expansion microscopy with lattice light-sheet microscopy for nanoscale imaging of fly and mouse neuronal circuits and their molecular constituents that’s roughly 1,000 times faster than other methods.
A study by UCLA researchers is the first to demonstrate a technique for coaxing pluripotent stem cells — which can give rise to every cell type in the body and which can be grown indefinitely in the lab — into becoming mature T cells capable of killing tumor cells.
For the first time it has been shown that a brief training session with rhythmic gestures has immediate benefits for narrative discourse in children of 5 and 6 years of age.
Dex-Net 4.0 enables “ambidextrous” robots to choose the best gripper for the job
Immuno-oncology player Five Prime is axing 20% of its workforce and its early-stage R&D in order to focus on its clinical cancer programs.
Life Biosciences has raised $50 million. The series B round will support the startup’s efforts to build a portfolio of subsidiaries with assets targeting eight aging pathways.
In 2018, the FDA approved 59 novel drugs, meaning approved new molecular entities. BioSpace analyzed new drug approvals from 2014 to 2018 to determine which companies were responsible for the most drug approvals in that period. Here’s a look.